Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse or Post-transplant Lymphoproliferative Disorder

Santa Monica California 90095

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Connecticut

New Haven Connecticut 06511

A clinical research study of INCB053914 for the treatment of Advanced Cancer

District of Columbia

Washington District of Columbia 20010

A clinical trial seeking patients for a research study for the treatment of Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse or Post-transplant Lymphoproliferative Disorder

Florida

Jacksonville Florida 32224

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Sarasota Florida 33916

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Georgia

Atlanta Georgia 30322

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Illinois

Chicago Illinois 60611

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Maryland

Baltimore Maryland 21201

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Massachusetts

Boston Massachusetts 02215

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Minnesota

Rochester Minnesota 55905

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

New York

New York New York 10065

A clinical research study of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific or Unspecified Childhood Solid Tumor, Protocol Specific

New York New York 10065

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

New York New York 10065

Patients are needed to participate in a clinical research study evaluating EBV-specific T-cells for the treatment of Non-Hodgkin's Lymphoma or Epstein-Barr Virus

Rochester New York 14642

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Ohio

Cincinnati Ohio 45229

A clinical trial to evaluate treatments using Tadekinig alfa and Placebo for patients with NLRC4-MAS or XIAP Deficiency

Columbus Ohio 43210

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Oklahoma

Oklahoma City Oklahoma 73104

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Pennsylvania

Pittsburgh Pennsylvania 15232

A clinical trial seeking patients for a research study for the treatment of Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse or Post-transplant Lymphoproliferative Disorder

Pittsburgh Pennsylvania 15224

A clinical trial to evaluate treatments using Tadekinig alfa and Placebo for patients with NLRC4-MAS or XIAP Deficiency

South Carolina

Charleston South Carolina 29425

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Tennessee

Nashville Tennessee 37203

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Nashville Tennessee 37232

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Texas

Houston Texas 77030

A clinical research study of INCB053914 for the treatment of Advanced Cancer

Houston Texas 77030

A clinical trial seeking patients for a research study for the treatment of Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse or Post-transplant Lymphoproliferative Disorder

Houston Texas 77030

A clinical trial seeking patients for a research study for the treatment of Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse or Post-transplant Lymphoproliferative Disorder

Houston Texas 77030-4009

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Australia

Randwick New South Wales 2031

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

South Brisbane Queensland 4101

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Westmead 2145

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Austria

Graz 8036

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Innsbruck 6020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Wien 1090

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Belgium

Brussels 1200

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Brussels 1020

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Ghent 9000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Leuven 3000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Liège 4000

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Czechia

Praha 5 150 06

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Denmark

Kobenhavn O 2100

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

France

Bobigny Cedex 93009

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Bordeaux 33076

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Lille 59037

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Lyon 69008

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

Marseille cedex 5 13385

A clinical trial to evaluate treatments using Blinatumomab and Conventional Consolidation Chemotherapy for patients with Acute Lymphoblastic Leukemia (ALL)

View More ▼

Montpellier Cedex 5 34295

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia

Nantes 44093

A Phase 1/Phase 2 clinical study for patients with Lymphoma or Lymphoma or Chronic Lymphocytic Leukemia